Biomarkers of Alzheimer’s Disease Associated with Programmed Cell Death Reveal Four Repurposed Drugs
Journal of Molecular Neuroscience · 2024
DOI: 10.1007/s12031-024-02228-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Neuroscience, 2024. Verfasst von Elif Kubat Oktem. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Istanbul Medeniyet University, North Campus, Istanbul, 347…. Hauptthemen laut MEDLINE: Alzheimer Disease, Drug Repositioning, Biomarkers, Apoptosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a neurodegenerative disorder and the most common cause of dementia. Programmed cell death (PCD) is mainly characterized by unique morphological features and energy-dependent biochemical processes. The predominant pathway leading to cell death in AD has not been thoroughly analyzed, although there is evidence of neuron loss in AD and numerous pathways of PCD have been associated with this process. A better understanding of the systems biology underlying the relationship between AD and PCD could lead to the development of new therapeutic approaches. To this end, publicly available transcriptome data were examined using bioinformatic methods such as differential gene expression and weighted gene coexpression network analysis (WGCNA) to find PCD-related AD biomarkers. The diagnostic significance of these biomarkers was evaluated using a logistic regression-based predictive model. Using these biomarkers, a multifactorial regulatory network was developed. Last, a drug repositioning study was conducted to propose new drugs for the treatment of AD targeting PCD. The development of 3PM (predictive, preventive, and personalized) drugs for the treatment of AD would be enabled by additional research on the effects of these drugs on this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Istanbul Medeniyet University, North Campus, Istanbul, 34700, Turkey. ekoktem@outlook.com.
Zitieren
APA
Kubat Oktem, E. (2024). Biomarkers of Alzheimer’s Disease Associated with Programmed Cell Death Reveal Four Repurposed Drugs. Journal of Molecular Neuroscience. https://doi.org/10.1007/s12031-024-02228-0
Vancouver
Kubat Oktem E. Biomarkers of Alzheimer’s Disease Associated with Programmed Cell Death Reveal Four Repurposed Drugs. Journal of Molecular Neuroscience. 2024. doi:10.1007/s12031-024-02228-0
BibTeX
@article{KubatOktem2024,
author = {Kubat Oktem, Elif},
title = {Biomarkers of Alzheimer’s Disease Associated with Programmed Cell Death Reveal Four Repurposed Drugs},
journal = {Journal of Molecular Neuroscience},
year = {2024},
doi = {10.1007/s12031-024-02228-0}
}
EUVIMED